Back to Search Results
Image Place holder

Louis Harrison, MD, FASTRO

SENIOR PHYSICIAN EXECUTIVE
Chair Emeritus of the Department of Radiation Oncology

 
Specialty: Radiation Oncology
Program: Radiation Oncology

Call 1-888-663-3488

Call 1-888-663-3488


Locations:
Overview

Cancer Focus: Basal Cell Carcinoma, Head and Neck Cancer, Merkel Cell Carcinoma, Oral Cavity or Throat Cancer, Skin Cancer (Nonmelanoma), Throat Cancer, Tongue Cancer

Dr. Harrison is the Chair Emeritus of the Department of Radiation Oncology at Moffitt Cancer Center. He is also the Senior Physician Executive at Moffitt. In this role as Senior Physician Executive, Dr. Harrison leads a variety of initiatives focused on Moffitt's growth and innovation, including new technologies and special projects and programs. He will also continue to work with Moffitt leadership to create new alliances and nurture the existing partnerships with other health systems which he was instrumental in creating. Dr. Harrison served as Chair of the Department of Radiation Oncology at Moffitt from 2014-2021. During this period, he led the entire rebuilding of the Department and Program, including major faculty recruitments, technology developments, expansions to new markets and overall growth. The department more than doubled in size under his leadership. A key component in the FORT (Future of Radiation Therapy) research program, aimed at re-imagining the paradigms of radiation therapy treatments and developing new innovations in personalized, adaptive and biologically driven treatment programs. The Radiation Oncology research program grew exponentially under his tenure. He stepped down from the Chair role in February 2021 and now serves as Chair Emeritus.  He received his MD degree from the S.U.N.Y. Downstate Medical Center College of Medicine. He completed a Radiation Oncology Residency at Yale University School of Medicine, Yale-New Haven Hospital; and also served as Chief Resident. Following residency, Dr. Harrison joined the faculty at Memorial Sloan-Kettering Cancer Center in New York. While at Memorial, he was the Chief of the Brachytherapy Service in the Department of Radiation Oncology as well as the Institutional Program Leader of the multidisciplinary Head and Neck Cancer Disease Management Team. He joined the Continuum Health Partners (Beth Israel Medical Center, St. Luke's and Roosevelt Hospitals and NY Eye and Ear Infirmary) in 1997. At Continuum, Dr. Harrison served as Chairman and Gerald J. Friedman Endowed Chair of Radiation Oncology and Physician-in-Chief of Continuum Cancer Centers of New York. Dr. Harrison was also appointed as Professor of Radiation Oncology and Otorhinolaryngology-Head and Neck Surgery at the Albert Einstein College of Medicine. He has served as Chairman of the Board and President of ASTRO, the leading radiation oncology professional society in the country, as well as President of the American Brachytherapy Society and President of the International Society of Intraoperative Radiation Therapy. The American Society for Radiation Oncology (ASTRO) named Dr. Harrison as a 2017 ASTRO Gold Medalist, the highest honor bestowed upon ASTRO members who have made outstanding lifetime contributions in the field of radiation oncology.  Dr. Harrison serves on the Board of Directors of the National Comprehensive Cancer Network (NCCN), where he also has been elected to the Executive Committee. Dr Harrison is the senior editor of the textbook Head and Neck Cancer: A Multidisciplinary Approach, now in its fourth edition. He is also a co-editor of Intraoperative Irradiation: Techniques and Results, now in its second edition. Dr Harrison has received numerous awards including the Alpha Omega Alpha Honor Medical Society, Clarence Dennis Society Prize, and the Henscke Award for Brachytherapy, the Physician of Excellence Award from the American Cancer Society and the Boyer Prize for Biomedical Research at Memorial Sloan Kettering Cancer Center.       


Education & Training

Residency:

  • Yale University School of Medicine - Therapeutic Radiology

Medical School:

  • SUNY Downstate Medical Center - MD
Video Profile
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Kim S, Wuthrick E, Blakaj D, Eroglu Z, Verschraegen C, Thapa R, Mills M, Dibs K, Liveringhouse C, Russell J, Caudell JJ, Tarhini A, Markowitz J, Kendra K, Wu R, Chen DT, Berglund A, Michael L, Aoki M, Wang MH, Hamaidi I, Cheng P, de la Iglesia J, Slebos RJ, Chung CH, Knepper TC, Moran-Segura CM, Nguyen JV, Perez BA, Rose T, Harrison L, Messina JL, Sondak VK, Tsai KY, Khushalani NI, Brohl AS. Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial. Lancet. 2022 Sep.400(10357):1008-1019. Pubmedid: 36108657. Pmcid: PMC9533323.
  • Song EY, Chuang J, Frakes JM, Dilling T, Quinn JF, Rosenberg S, Johnstone P, Harrison L, Hoffe SE. Developing a Dedicated Leadership Curriculum for Radiation Oncology Residents. J Cancer Educ. 2022 Oct.37(5):1446-1453. Pubmedid: 33619686.
  • Katsoulakis E, Kudner R, Chapman C, Park J, Puckett L, Solanki A, Kapoor R, Hagan M, Kelly M, Palta J, Tishler R, Hitchcock Y, Chera B, Feygelman V, Walker G, Sher D, Kujundzic K, Wilson E, Dawes S, Yom S, Harrison L. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Pa. Pract Radiat Oncol. 2022 Jun.12(5):409-423. Pubmedid: 35667551.
  • Park J, Puckett LL, Katsoulakis E, Venkatesulu BP, Kujundzic K, Solanki AA, Movsas B, Simone CB, Sandler H, Lawton CA, Das P, Wo JY, Buchholz TA, Fisher CM, Harrison LB, Sher DJ, Kapoor R, Chapman CH, Dawes S, Kudner R, Wilson E, Hagan M, Palta J, Kelly MD. Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. Pract Radiat Oncol. 2022 Jun.12(6):468-474. Pubmedid: 35690354.
  • Daniel Grass G, Alfonso JCL, Welsh E, Ahmed KA, Teer JK, Pilon-Thomas S, Harrison LB, Cleveland JL, Mulé JJ, Eschrich SA, Enderling H, Torres-Roca JF. The Radiosensitivity Index Gene Signature Identifies Distinct Tumor Immune Microenvironment Characteristics Associated With Susceptibility to Radiation Therapy. Int J Radiat Oncol Biol Phys. 2022 Jul.113(3):635-647. Pubmedid: 35289298. Pmcid: PMC9250625.
  • Kirtane KS, Zahid MU, Enderling H, Harrison LB. Reimagining Cancer Staging in the Era of Evolutionary Oncology. J Natl Compr Canc Ne. 2022 Dec.20(12):1370-1372. Pubmedid: 36509079.
  • de la Iglesia JV, Slebos RJC, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell J, Harrison L, Wenig BM, Conejo-Garcia J, Hernandez-Prera JC, Chung CH. Correction: Effects of Tobacco Smoking On the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2021 Sep.27(17):4941. Pubmedid: 34470812.
  • Yang G, Yuan Z, Ahmed K, Welsh EA, Fulp WJ, Gonzalez RJ, Mullinax JE, Letson D, Bui M, Harrison LB, Scott JG, Torres-Roca JF, Naghavi AO. Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization. Transl Oncol. 2021 Oct.14(10):101165. Pubmedid: 34246048. Pmcid: PMC8274330.
  • Zahid MU, Mohsin N, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model. Int J Radiat Oncol Biol Phys. 2021 Nov.111(3):693-704. Pubmedid: 34102299. Pmcid: PMC8463501.
  • Alfonso JCL, Grass GD, Welsh E, Ahmed KA, Teer JK, Pilon-Thomas S, Harrison LB, Cleveland JL, Mulé JJ, Eschrich SA, Torres-Roca JF, Enderling H. Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability. Neoplasia. 2021 Nov.23(11):1110-1122. Pubmedid: 34619428. Pmcid: PMC8502777.
  • Zahid MU, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization. J Pers Med. 2021 Nov.11(11). Pubmedid: 34834476. Pmcid: PMC8622616.
  • Scott JG, Sedor G, Scarborough JA, Kattan MW, Peacock J, Grass GD, Mellon EA, Thapa R, Schell M, Waller A, Poppen S, Andl G, Teer J, Eschrich SA, Dilling TJ, Dalton WS, Harrison LB, Fox T, Torres-Roca JF. Personalizing Radiotherapy Prescription Dose Using Genomic Markers of Radiosensitivity and Normal Tissue Toxicity in NSCLC. J Thorac Oncol. 2021 Mar.16(3):428-438. Pubmedid: 33301984. Pmcid: PMC8549863.
  • Gerson SL, Shaw K, Harrison LB, Holcombe RF, Hutchins L, Lee CB, Loehrer PJ, Mulkerin D, Purcell WT, Teston L, Weiner LM, Weiner GJ. Status of Cancer Care at Network Sites of the Nation's Academic Cancer Centers. J Natl Compr Canc Ne. 2021 Mar.19(6):726-732. Pubmedid: 33706258.
  • Campbell SR, Shah C, Scott JG, Mesko N, Nystrom L, Kolar M, Largo AC, Kamrava M, Mourtada F, Naghavi AO, Harrison LB. American Brachytherapy Society (ABS) consensus statement for soft-tissue sarcoma brachytherapy. Brachytherapy. 2021 Jul.20(6):1200-1218. Pubmedid: 34303600.
  • Yuan Z, Frazer M, Rishi A, Latifi K, Tomaszewski MR, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Zhang GG, Frakes JM. Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy. Rep Pract Oncol Radiother. 2021 Feb.26(1):29-34. Pubmedid: 33948299. Pmcid: PMC8086711.
  • Byun DJ, Tam MM, Jacobson AS, Persky MS, Tran TT, Givi B, DeLacure MD, Li Z, Harrison LB, Hu KS. Prognostic potential of mid-treatment nodal response in oropharyngeal squamous cell carcinoma. Head Neck. 2020 Sep. Pubmedid: 32964574.
  • Yang GQ, Harrison LB. A Hard Target Needs a Sharper DaRT. Int J Radiat Oncol Biol Phys. 2020 May.107(1):152-153. Pubmedid: 32277913.
  • de la Iglesia JV, Slebos RJ, Martin-Gomez L, Wang X, Teer JK, Tan AC, Gerke TA, Aden-Buie G, Van Veen T, Masannat J, Chaudhary R, Song F, Fournier M, Siegel EM, Schabath MB, Wadsworth JT, Caudell JJ, Harrison LB, Wenig B, Conejo-Garcia JR, Hernandez-Prera JC, Chung CH. Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2020 Mar.26(6):1474-1485. Pubmedid: 31848186. Pmcid: PMC7073297.
  • Yuan Z, Frazer M, Zhang GG, Latifi K, Moros EG, Feygelman V, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Harrison LB, Hoffe SE, Frakes JM. CT-based radiomic features to predict pathological response in rectal cancer: A retrospective cohort study. J Med Imaging Radiat Oncol. 2020 Jun.64(3):444-449. Pubmedid: 32386109.
  • Sim AJ, Redler G, Peacock J, Naso C, Wasserman S, McNitt KB, Hoffe SE, Johnstone PAS, Harrison LB, Rosenberg SA. Harnessing COVID-Driven Technical Innovations for Improved Multi-Disciplinary Cancer Care in the Post-COVID Era: The Virtual Patient Room. Cancer Control. 2020 Jan.27(1). Pubmedid: 33023342. Pmcid: PMC7791470.
  • Rishi A, Zhang GG, Yuan Z, Sim AJ, Song EY, Moros EG, Tomaszewski MR, Latifi K, Pimiento JM, Fontaine JP, Mehta R, Harrison LB, Hoffe SE, Frakes JM. Pretreatment CT and 18 F-FDG PET-based radiomic model predicting pathological complete response and loco-regional control following neoadjuvant chemoradiation in oesophageal cancer. J Med Imaging Radiat Oncol. 2020 Dec.65(1):102-111. Pubmedid: 33258556.
  • Mendenhall WM, Strojan P, Beitler JJ, Langendijk JA, Suarez C, Lee AW, Rinaldo A, Rodrigo JP, Smee R, Eisbruch A, Harrison LB, Corry J, Ferlito A. Radiotherapy for parapharyngeal space tumors. Am J Otolaryngol. 2019 Mar.40(2):289-291. Pubmedid: 30621929.
  • Latifi K, Moros EG, Zhang G, Harrison L, Feygelman V. A Method to Determine the Coincidence of MRI-Guided Linac Radiation and Magnetic Isocenters. Technol Cancer Res Treat. 2019 Jan.18. Pubmedid: 31537173. Pmcid: PMC6755638.
  • Perez MC, Oliver DE, Weitman ES, Boulware D, Messina JL, Torres-Roca J, Cruse CW, Gonzalez RJ, Sarnaik AA, Sondak VK, Wuthrick EJ, Harrison LB, Zager JS. Management of Sentinel Lymph Node Metastasis in Merkel Cell Carcinoma: Completion Lymphadenectomy, Radiation, or Both?. Ann Surg Oncol. 2019 Feb.26(2):379-385. Pubmedid: 30311164. Pmcid: PMC7771265.
  • Enderling H, Alfonso JCL, Moros E, Caudell JJ, Harrison LB. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy. Trends Cancer. 2019 Aug.5(8):467-474. Pubmedid: 31421904.
  • Grass GD, Mills MN, Ahmed KA, Liveringhouse CL, Montejo ME, Robinson TJ, Chavez JC, Harrison LB, Kim S. Radiotherapy for early stage diffuse large B-cell lymphoma with or without double or triple hit genetic alterations. Leuk Lymphoma. 2019 Apr.60(4):886-893. Pubmedid: 30457458. Pmcid: PMC6596288.
  • Oliver DE, Mohammadi H, Figura N, Frakes JM, Yamoah K, Perez BA, Wuthrick EJ, Naghavi AO, Caudell JJ, Harrison LB, Torres-Roca JF, Ahmed KA. Novel Genomic-Based Strategies to Personalize Lymph Node Radiation Therapy. Semin Radiat Oncol. 2019 Apr.29(2):111-125. Pubmedid: 30827449.
  • López Alfonso JC, Poleszczuk J, Walker R, Kim S, Pilon-Thomas S, Conejo-Garcia JJ, Soliman H, Czerniecki B, Harrison LB, Enderling H. Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery. JCO Clin Cancer Inform. 2019 Apr.3:1-16. Pubmedid: 30964698. Pmcid: PMC6661069.
  • Wuthrick EJ, Harrison LB. A Deep Dive into the Diagnosis and Management of Regional Lymph Node Metastases. Semin Radiat Oncol. 2019 04.29(2):91-92. Pubmedid: 30827457.
  • Perez MC, de Pinho FR, Holstein A, Oliver DE, Naqvi SMH, Kim Y, Messina JL, Burke E, Gonzalez RJ, Sarnaik AA, Cruse CW, Wuthrick EJ, Harrison LB, Sondak VK, Zager JS. Resection Margins in Merkel Cell Carcinoma: Is a 1-cm Margin Wide Enough?. Ann Surg Oncol. 2018 Oct.25(11):3334-3340. Pubmedid: 30073600. Pmcid: PMC7771268.
  • Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Venkat PS, Ahmed KA, Demetriou S, Frakes JM, Kim Y, Kish JA, Russell JS, Otto KJ, Chung CH, Harrison LB, Trotti A, Caudell JJ. Patient choice for high-volume center radiation impacts head and neck cancer outcome. Cancer Med. 2018 Oct.7(10):4964-4979. Pubmedid: 30175512. Pmcid: PMC6198196.
  • Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A. Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al. Pract Radiat Oncol. 2018 Nov.8(3):e185-e186. Pubmedid: 29724403.
  • Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A. Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2018 Mar.7(4):246-253. Pubmedid: 28428019.
  • Walker R, Poleszczuk J, Pilon-Thomas S, Kim S, Anderson AARA, Czerniecki BJ, Harrison LB, Moros EG, Enderling H. Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy. Sci Rep. 2018 Jun.8(1):9474. Pubmedid: 29930290. Pmcid: PMC6013469.
  • Oliver DE, Sondak VK, Strom T, Zager JS, Naghavi AO, Sarnaik A, Messina JL, Caudell JJ, Trotti AM, Torres-Roca JF, Khushalani NI, Harrison LB. Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience. Melanoma Manag. 2018 Jun.5(1):MMT02. Pubmedid: 30190928. Pmcid: PMC6122528.
  • Naghavi AO, Fernandez DC, Mesko N, Juloori A, Martinez A, Scott JG, Shah C, Harrison LB. American Brachytherapy Society consensus statement for soft tissue sarcoma brachytherapy. Brachytherapy. 2018 Jan.16(3):466-489. Pubmedid: 28342738.
  • Rossetti A, Chadha M, Torres BN, Lee JK, Hylton D, Loewy JV, Harrison LB. The Impact of Music Therapy on Anxiety in Cancer Patients Undergoing Simulation for Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 Sep.99(1):103-110. Pubmedid: 28816136. Pmcid: PMC7864375.
  • Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF. Tumour radiosensitivity is associated with immune activation in solid tumours. Eur J Cancer. 2017 Oct.84:304-314. Pubmedid: 28863385. Pmcid: PMC5822441.
  • Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol. 2017 May.18(5):e266-e273. Pubmedid: 28456586. Pmcid: PMC7771279.
  • Goff PH, Harrison LB, Furhang E, Ng E, Bhatia S, Trichter F, Ennis RD. 2D kV orthogonal imaging with fiducial markers is more precise for daily image guided alignments than soft-tissue cone beam computed tomography for prostate radiation therapy. Adv Radiat Oncol. 2017 May.2(3):420-428. Pubmedid: 29114611. Pmcid: PMC5605315.
  • Ahmed KA, Kim S, Arrington J, Naghavi AO, Dilling TJ, Creelan BC, Antonia SJ, Caudell JJ, Harrison LB, Sahebjam S, Gray JE, Etame AB, Johnstone PA, Yu M, Perez BA. Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastases. J Neurooncol. 2017 Jun.133(2):331-338. Pubmedid: 28466250.
  • Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Res. 2017 Jun.19(1):75. Pubmedid: 28666457. Pmcid: PMC5493088.
  • Naghavi AO, Gonzalez RJ, Scott JG, Mullinax JE, Abuodeh YA, Kim Y, Binitie O, Ahmed KA, Bui MM, Saini AS, Zager JS, Biagioli MC, Letson D, Harrison LB, Fernandez DC. Implications of staged reconstruction and adjuvant brachytherapy in the treatment of recurrent soft tissue sarcoma. Brachytherapy. 2017 Jul.15(4):495-503. Pubmedid: 27180128. Pmcid: PMC7771533.
  • Ahmed KA, Kim S, Harrison LB. Novel Opportunities to Use Radiation Therapy with Immune Checkpoint Inhibitors for Melanoma Management. Surg Oncol Clin N Am. 2017 Jul.26(3):515-529. Pubmedid: 28576186.
  • Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney BE, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul.70:14-22. Pubmedid: 28622886.
  • Strom T, Naghavi AO, Messina JL, Kim S, Torres-Roca JF, Russell J, Sondak VK, Padhya TA, Trotti AM, Caudell JJ, Harrison LB. Improved local and regional control with radiotherapy for Merkel cell carcinoma of the head and neck. Head Neck. 2017 Jan.39(1):48-55. Pubmedid: 27300153.
  • Strom TJ, Naghavi AO, Trotti AM, Russell J, Kish JA, McCaffrey J, Otto KJ, Harrison LB, Caudell JJ. Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years. Geriatr Oncol. 2017 Jan.8(1):50-55. Pubmedid: 27720129.
  • Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, Moros E, Dalton WS, Eschrich SA, McLeod H, Harrison LB, Torres-Roca JF. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. Lancet Oncol. 2017 Feb.18(2):202-211. Pubmedid: 27993569. Pmcid: PMC7771305.
  • Gamez ME, Agarwal M, Hu KS, Lukens JN, Harrison LB. Hypofractionated Palliative Radiotherapy with Concurrent Radiosensitizing Chemotherapy for Advanced Head and Neck Cancer Using the "QUAD-SHOT Regimen". Anticancer Res. 2017 Feb.37(2):685-691. Pubmedid: 28179317.
  • Naghavi AO, Gonzalez RJ, Scott JG, Kim Y, Abuodeh YA, Strom TJ, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB, Fernandez DC. Staged reconstruction brachytherapy has lower overall cost in recurrent soft-tissue sarcoma. J Contemp Brachytherapy. 2017 Feb.9(1):20-29. Pubmedid: 28344600. Pmcid: PMC5346606.
  • Takácsi-Nagy Z, Martínez-Mongue R, Mazeron JJ, Anker CJ, Harrison LB. American Brachytherapy Society Task Group Report: Combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy. 2017 Aug.16(1):44-58. Pubmedid: 27592129.
  • Hu KS, Mourad WF, Gamez M, Safdieh J, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney B, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017 Aug.39(8):1647-1654. Pubmedid: 28474380.
  • Strom T, Torres-Roca JF, Parekh A, Naghavi AO, Caudell JJ, Oliver DE, Messina JL, Khushalani NI, Zager JS, Sarnaik A, Mulé JJ, Trotti AM, Eschrich SA, Sondak VK, Harrison LB. Regional Radiation Therapy Impacts Outcome for Node-Positive Cutaneous Melanoma. J Natl Compr Canc Ne. 2017 Apr.15(4):473-482. Pubmedid: 28404758. Pmcid: PMC7771284.
  • Abuodeh Y, Ahmed K, Echevarria M, Naghavi A, Grass GD, Robinson TJ, Tomblyn M, Shah B, Chavez J, Bello C, El-Haddad G, Harrison L, Kim S. Priming radioimmunotherapy with external beam radiation in patients with relapsed low grade non-Hodgkin lymphoma. Ther Adv Hematol. 2017 Apr.8(4):129-138. Pubmedid: 28491264. Pmcid: PMC5405899.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. In Reply to Zhang. Int J Radiat Oncol Biol Phys. 2017 10.99(2):501. Pubmedid: 28872005.
  • Scott JG, Harrison LB, Torres-Roca JF. Genomic biomarkers for precision radiation medicine - Authors' reply. Lancet Oncol. 2017 05.18(5):e239. Pubmedid: 28495285.
  • Scott JG, Harrison LB, Torres-Roca JF. Genomic-adjusted radiation dose - Authors' reply. Lancet Oncol. 2017 03.18(3):e129. Pubmedid: 28271862.
  • Harrison LB. Clinical Trial or Unilateral RT with Cisplatin. Int J Radiat Oncol Biol Phys. 2017 01.97(1):5. Pubmedid: 27979457.
  • Parikh RR, Goodman RR, Rhome R, Sudentas E, Trichter F, Harrison LB, Choi W. Linear accelerator-based flattening-filter-free stereotactic radiosurgery for trigeminal neuralgia: Feasibility and patient-reported outcomes. Pract Radiat Oncol. 2016 Oct.6(1):e1-e7. Pubmedid: 26577003.
  • Mourad WF, Patel S, Young R, Khorsandi AS, Concert C, Shourbaji RA, Ciarrocca K, Bakst RL, Shasha D, Guha C, Garg MK, Hu KS, Kalnicki S, Harrison LB. Management algorithm for HIV-associated parotid lymphoepithelial cysts. Eur Arch Otorhinolaryngol. 2016 Oct.273(10):3355-3362. Pubmedid: 26879995.
  • Strom T, Carr M, Zager JS, Naghavi A, Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, Kim S, Torres-Roca JF, Padhya TA, Sondak VK, Trotti AM, Harrison LB, Caudell JJ. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma. Ann Surg Oncol. 2016 Oct.23(11):3572-3578. Pubmedid: 27251134.
  • Grass GD, Peacock J, Latifi K, Zhang GG, Mills M, Garcia G, Harrison LB, Kim S. Spatial Patterns of Local Failure Following Chemotherapy in Hodgkin Lymphoma: Volume Reduction From Involved Site/Nodal Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):S39. Pubmedid: 27675917.
  • Abuodeh YA, Ahmed KA, Echevarria M, Naghavi AO, Grass GD, Tomblyn MB, Harrison LB, Kim S. Priming Radioimmunotherapy With External Beam Radiation in Patients With Relapsed Low-Grade Non-Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):S164. Pubmedid: 27675684.
  • Parekh A, Strom T, Naghavi AO, Caudell JJ, Zager JS, Messina JL, Torres-Roca JF, Sondak VK, Trotti A, Harrison LB. Does Regional Radiation Therapy Impact Outcome for High-Risk, Node-Positive Cutaneous Melanoma?. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):S157. Pubmedid: 27675666.
  • Naghavi AO, Echevarria M, Strom T, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ. Race Is Associated With Poor Outcomes in Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):E407. Pubmedid: 27674609.
  • Naghavi AO, Gonzalez RJ, Scott JG, Abuodeh YA, Echevarria M, Mullinax JE, Ahmed KA, Harrison LB, Fernandez DC. Staged Reconstruction Brachytherapy Has Lower Overall Cost in Recurrent Soft Tissue Sarcoma. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):E398-E399. Pubmedid: 27674581.
  • Naghavi AO, Strom T, Abuodeh YA, Frakes JM, Ahmed KA, Harrison LB, Trotti A, Caudell JJ. Risk Factors for Recurrence in Human Papillomavirus-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):E372-E373. Pubmedid: 27674513.
  • Naghavi AO, Strom T, Abuodeh YA, Echevarria M, Russell J, Kish JA, Balducci L, Trotti A, Harrison LB, Caudell JJ. Concurrent Chemotherapy in Elderly Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2016 Oct.96(2S):E362. Pubmedid: 27674484.
  • Mifsud MJ, Tanvetyanon T, Mccaffrey JC, Otto KJ, Padhya TA, Kish J, Trotti AM, Harrison LB, Caudell JJ. Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas. Head Neck. 2016 Nov.38(11):1628-1633. Pubmedid: 27098984.
  • Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, Kim Y, Trotti AM, Harrison LB, Yamoah K, Caudell JJ. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016 Nov.122(22):3529-3537. Pubmedid: 27479362. Pmcid: PMC7810134.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma. Leuk Lymphoma. 2016 May.57(5):1074-1082. Pubmedid: 26374099.
  • Konski A, Yu JB, Freedman G, Harrison LB, Johnstone PA, Konski A, Yu JB, Freedman G, Harrison LB, Johnstone PA. Radiation Oncology Practice: Adjusting to a New Reimbursement Model. J Oncol Pract. 2016 May.12(5):e576-e583. Pubmedid: 27006359.
  • Ahmed KA, Stallworth DG, Kim Y, Johnstone PA, Harrison LB, Caudell JJ, Yu HH, Etame AB, Weber JS, Gibney GT. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. Ann Oncol. 2016 Mar.27(3):434-441. Pubmedid: 26712903.
  • Strom TJ, Caudell JJ, Harrison LB. Management of BCC and SCC of the Head and Neck. Cancer Control. 2016 Jul.23(3):220-227. Pubmedid: 27556662.
  • Naghavi AO, Strom TJ, Ahmed KA, Echevarria MI, Abuodeh YA, Venkat PS, Frakes JM, Harrison LB, Trotti AM, Caudell JJ. Management of Oropharyngeal Cancer in the HPV Era. Cancer Control. 2016 Jul.23(3):197-207. Pubmedid: 27556659.
  • Harrison LB, Caudell JJ. Maximizing Cures and Preserving Function in Head and Neck Cancers. Cancer Control. 2016 Jul.23(3):192. Pubmedid: 27556658.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma. Radiother Oncol. 2016 Jan.118(1):52-59. Pubmedid: 26522061.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival. Leuk Lymphoma. 2016 Feb.57(2):320-327. Pubmedid: 26110882. Pmcid: PMC5593757.
  • Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer. Cancer. 2016 Feb.122(4):634-641. Pubmedid: 26565997.
  • Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, Naghavi AO, Kim S, Kim Y, Patel BG, Sarangkasiri S, Johnstone PA, Sahebjam S, Khushalani NI, Forsyth PA, Harrison LB, Yu M, Etame AB, Caudell JJ. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ann Oncol. 2016 Dec.27(12):2288-2294. Pubmedid: 27637745. Pmcid: PMC8890451.
  • Naghavi AO, Echevarria MI, Strom TJ, Abuodeh YA, Ahmed KA, Venkat PS, Trotti A, Harrison LB, Green BL, Yamoah K, Caudell JJ. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016 Dec.45:18-25. Pubmedid: 27664388.
  • Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head Neck. 2016 Apr.38 Suppl 1:E2151-E2158. Pubmedid: 25735803.
  • Strom T, Harrison LB. Radiotherapy for management of basal and squamous cell carcinoma. Curr Prob Cancer. 2015 Sep.39(4):237-247. Pubmedid: 26364698.
  • Parikh RR, Grossbard ML, Green BL, Harrison LB, Yahalom J. Disparities in survival by insurance status in patients with Hodgkin lymphoma. Cancer. 2015 Oct.121(19):3515-3524. Pubmedid: 26058564.
  • Parikh RR, Grossbard ML, Harrison LB, Yahalom J. Early-Stage Classic Hodgkin Lymphoma: The Utilization of Radiation Therapy and Its Impact on Overall Survival. Int J Radiat Oncol Biol Phys. 2015 Nov.93(3):684-693. Pubmedid: 26279323.
  • Parikh RR, Moskowitz BK, Maher E, Della Rocca D, Della Rocca R, Culliney B, Shapira I, Grossbard ML, Harrison LB, Hu K. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy. Leuk Lymphoma. 2015 May.56(5):1266-1270. Pubmedid: 25356924.
  • Ennis KY, Chen MH, Smith GC, D'Amico AV, Zhang Y, Quinn SA, Ryemon SN, Goltz D, Harrison LB, Ennis RD. The Impact of Economic Recession on the Incidence and Treatment of Cancer. J Cancer. 2015 Jun.6(8):727-733. Pubmedid: 26185534. Pmcid: PMC4504108.
  • Ko HC, Gupta V, Mourad WF, Hu KS, Harrison LB, Som PM, Bakst RL. A contouring guide for head and neck cancers with perineural invasion. Pract Radiat Oncol. 2015 Jul.4(6):e247-e258. Pubmedid: 25407876.
  • Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, Lee JK, Myerson R, Harrison LB, Enderling H. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiat Oncol. 2015 Jul.10:159. Pubmedid: 26227259. Pmcid: PMC4521490.
  • Strojan P, Corry J, Eisbruch A, Vermorken JB, Mendenhall WM, Lee AW, Haigentz M, Beitler JJ, de Bree R, Takes RP, Paleri V, Kelly CG, Genden EM, Bradford CR, Harrison LB, Rinaldo A, Ferlito A. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. 2015 Jan.37(1):134-150. Pubmedid: 24481720.
  • Gamez M, Hu K, Harrison LB. RETRACTED: Laryngeal Function After Radiation Therapy. Otolaryng Clin N Am. 2015 08.48(4):585-599. Pubmedid: 26092763.
  • Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. Am J Clin Oncol. 2014 Feb.37(1):57-62. Pubmedid: 23357967.
  • Welk G, Fischman MG, Greenleaf C, Harrison L, Ransdell L, van der Mars H, Zhu W. Editorial Board Position statement regarding the Declaration on Research Assessment (DORA) recommendations with respect to journal impact factors. Res Q Exerc Sport. 2014 Dec.85(4):429-430. Pubmedid: 25412123.
  • Nicholas Lukens J, Gamez M, Hu K, Harrison LB. Modern brachytherapy. Semin Oncol. 2014 Dec.41(6):831-847. Pubmedid: 25499641.
  • Debenham BJ, Hu KS, Harrison LB. Present status and future directions of intraoperative radiotherapy. Lancet Oncol. 2013 Oct.14(11):e457-e464. Pubmedid: 24079873.
  • Mourad WF, Shasha D, Blakaj DM, Khorsandi AS, Shourbaji RA, Glanzman J, Kabarriti R, Young R, Patel S, Katsoulakis E, Gámez M, Woode R, Lazarus C, Concert C, Hu KS, Harrison LB. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Res. 2013 Oct.33(10):4483-4489. Pubmedid: 24123019.
  • Chadha M, Woode R, Sillanpaa J, Lucido D, Boolbol SK, Kirstein L, Osborne MP, Feldman S, Harrison LB. Early-stage breast cancer treated with 3-week accelerated whole-breast radiation therapy and concomitant boost. Int J Radiat Oncol Biol Phys. 2013 May.86(1):40-44. Pubmedid: 23290443.
  • Becker DJ, Talwar S, Levy BP, Thorn M, Roitman J, Blum RH, Harrison LB, Grossbard ML. Impact of oncology drug shortages on patient therapy: unplanned treatment changes. J Oncol Pract. 2013 Jul.9(4):e122-e128. Pubmedid: 23942928. Pmcid: PMC3710178.
  • Mourad WF, Hauerstock D, Shourbaji RA, Hu KS, Culliney B, Li Z, Jacobson A, Tran T, Manolidis S, Schantz S, Urken M, Persky M, Harrison LB. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. Am J Clin Oncol. 2013 Dec.36(6):584-588. Pubmedid: 22992621.
  • Mourad WF, Hu KS, Shourbaji RA, Woode R, Harrison LB. Long-term follow-up and pattern of failure for T1-T2 glottic cancer after definitive radiation therapy. Am J Clin Oncol. 2013 Dec.36(6):580-583. Pubmedid: 22868239.
  • Mourad WF, Hu KS, Shourbaji RA, Khorsandi A, Harrison LB. Cranial Nerves Contouring Among Patients Treated With IMRT for Base of Skull, Nasopharyngeal, and Paranasal Sinus Cancer. Pract Radiat Oncol. 2013 Apr.3(2 Suppl 1):S34. Pubmedid: 24674554.
  • Mourad WF, Shourbaji RA, Ishihara D, Lin W, Hu KS, Harrison LB. The impact of computed tomography on early glottic cancer outcomes. Pract Radiat Oncol. 2013 Apr.3(2 Suppl 1):S33. Pubmedid: 24674553.
  • Chadha M, Vongtama D, Friedmann P, Parris C, Boolbol SK, Woode R, Harrison LB. Comparative acute toxicity from whole breast irradiation using 3-week accelerated schedule with concomitant boost and the 6.5-week conventional schedule with sequential boost for early-stage breast cancer. Clin Breast Cancer. 2012 Feb.12(1):57-62. Pubmedid: 22056970.
  • Serra D, Parris CR, Carper E, Homel P, Fleishman SB, Harrison LB, Chadha M. Outcomes of guided imagery in patients receiving radiation therapy for breast cancer. Clin J Oncol Nurs. 2012 Dec.16(6):617-623. Pubmedid: 23178354.
  • Chadha M, Portenoy J, Boolbol SK, Gillego A, Harrison LB. Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?. Int J Surg Oncol. 2012 Aug.2012:423520. Pubmedid: 22778939. Pmcid: PMC3384903.
  • Chadha M, Young A, Geraghty C, Masino R, Harrison L. Image guidance using 3D-ultrasound (3D-US) for daily positioning of lumpectomy cavity for boost irradiation. Radiat Oncol. 2011 May.6:45. Pubmedid: 21554697. Pmcid: PMC3113959.
  • Kligler B, Homel P, Harrison LB, Sackett E, Levenson H, Kenney J, Fleishman SB, Serra D, Merrell W. Impact of the Urban Zen Initiative on patients' experience of admission to an inpatient oncology floor: a mixed-methods analysis. J Altern Complement Med. 2011 Aug.17(8):729-734. Pubmedid: 21745096.
  • Harrison LB, Zietman AL. American society for radiation oncology intersociety summit summary. Int J Radiat Oncol Biol Phys. 2010 Mar.76(3):643-648. Pubmedid: 20159358.
  • Furhang EE, Dolan J, Sillanpaa JK, Harrison LB. Automating the initial physics chart checking process. J Appl Clin Med Phys. 2009 Feb.10(1):129-135. Pubmedid: 19223834. Pmcid: PMC5720507.
  • Chen C, Kane M, Song J, Campana J, Raben A, Hu K, Harrison L, Quon H, Dancey J, Baron A, Said S, Eckhardt SG, Raben D. Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer. J Clin Oncol. 2007 Nov.25(31):4880-4886. Pubmedid: 17971583.
  • Mehta PS, Harrison LB. Function and organ preservation in adult cancers of the head and neck. Expert Rev Anticancer Ther. 2007 Mar.7(3):361-371. Pubmedid: 17338655.
  • Su YB, Vickers AJ, Zelefsky MJ, Kraus DH, Shaha AR, Shah JP, Serio AM, Harrison LB, Bosl GJ, Pfister DG. Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J. 2006 May.12(3):182-188. Pubmedid: 16803675.
  • Chiu-Tsao ST, Ho Y, Shankar R, Wang L, Harrison LB. Energy dependence of response of new high sensitivity radiochromic films for megavoltage and kilovoltage radiation energies. Med Phys. 2005 Nov.32(11):3350-3354. Pubmedid: 16370422.
  • Hu K, Harrison LB. Impact of anemia in patients with head and neck cancer treated with radiation therapy. CURR TREAT OPTION ON. 2005 Jan.6(1):31-45. Pubmedid: 15610713.
  • Shasha D, Cremieux P, Harrison L. Relationship between hemoglobin levels and quality of life during radiation therapy plus concomitant or sequential chemotherapy in patients with cancer and anemia treated with epoetin alfa. J Natl Compr Canc Ne. 2004 Sep.2(5):509-517. Pubmedid: 19780258.
  • Chiu-Tsao ST, Duckworth T, Zhang C, Patel NS, Hsiung CY, Wang L, Shih JA, Harrison LB. Dose response characteristics of new models of GAFCHROMIC films: dependence on densitometer light source and radiation energy. Med Phys. 2004 Sep.31(9):2501-2508. Pubmedid: 15487731.
  • Patel NS, Chiu-Tsao ST, Shih JA, Ho Y, Tsao HS, Harrison LB. Treatment planning dosimetric parameters for 192Ir seed at short distances: effects of air channels and neighboring seeds based on Monte Carlo study. Med Phys. 2004 Jun.31(6):1521-1528. Pubmedid: 15259656.
  • Chiu-Tsao ST, Duckworth TL, Patel NS, Pisch J, Harrison LB. Verification of Ir-192 near source dosimetry using GAFCHROMIC film. Med Phys. 2004 Feb.31(2):201-207. Pubmedid: 15000605.
  • Shaiova L, Lapin J, Manco LS, Shasha D, Hu K, Harrison L, Portenoy RK. Tolerability and effects of two formulations of oral transmucosal fentanyl citrate (OTFC; ACTIQ) in patients with radiation-induced oral mucositis. Support Care Cancer. 2004 Apr.12(4):268-273. Pubmedid: 14750002.
  • Shasha D, George MJ, Harrison LB. Once-weekly dosing of epoetin-alpha increases hemoglobin and improves quality of life in anemic cancer patients receiving radiation therapy either concomitantly or sequentially with chemotherapy. Cancer. 2003 Sep.98(5):1072-1079. Pubmedid: 12942577.
  • Chiu-Tsao ST, Duckworth TL, Hsiung CY, Li Z, Williamson J, Patel NS, Harrison LB. Thermoluminescent dosimetry of the SourceTech Medical model STM1251 125I seed. Med Phys. 2003 Jul.30(7):1732-1735. Pubmedid: 12906190.
  • Harrison LB, Ferlito A, Shaha AR, Bradley PJ, Genden EM, Rinaldo A. Current philosophy on the management of cancer of the base of the tongue. Oral Oncol. 2003 Feb.39(2):101-105. Pubmedid: 12509962.
  • Hu K, Ship JA, Harrison LB. Rationale for integrating high-dose rate intraoperative radiation (HDR-IORT) and postoperative external beam radiation with subcutaneous amifostine for the management of stage III/IV head and neck cancer. Semin Oncol. 2003 Dec.30(6 Suppl 18):40-48. Pubmedid: 14727239.
  • Patel NS, Chiu-Tsao ST, Ho Y, Duckworth T, Shih JA, Tsao HS, Quon H, Harrison LB. High beta and electron dose from 192Ir: implications for "gamma" intravascular brachytherapy. Int J Radiat Oncol Biol Phys. 2002 Nov.54(3):972-980. Pubmedid: 12377352.
  • Maehara A, Patel NS, Harrison LB, Weissman NJ, Bui AB, Kim HS, Ajani AE, Castagna MT, McMillan TL, Yang N, Chan R, Pisch J, Quan H, Chiu-Tsao ST, Waksman R, Mintz GS. Dose heterogeneity may not affect the neointimal proliferation after gamma radiation for in-stent restenosis: a volumetric intravascular ultrasound dosimetric study. J Am Coll Cardiol. 2002 Jun.39(12):1937-1942. Pubmedid: 12084591.
  • Furhang EE, Hanley J, Chiu-Tsao ST, Toner S, Fan P, Gliedman P, Harrison LB. Clearance assurance for stereotactic radiosurgery and radiotherapy. Med Phys. 2002 Jan.29(1):45-50. Pubmedid: 11831572.
  • Friedlander P, Caruana S, Singh B, Shaha A, Kraus D, Harrison L, McKiernan J, Solan J, Polyak T, Shah JP. Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue. Head Neck. 2002 Feb.24(2):111-114. Pubmedid: 11891940.
  • Harrison LB, Chadha M, Hill RJ, Hu K, Shasha D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist. 2002 Dec.7(6):492-508. Pubmedid: 12490737.
  • Harrison LB, Shasha D, Homel P. Prevalence of anemia in cancer patients undergoing radiotherapy: prognostic significance and treatment. Oncology-Basel. 2002.63 Suppl 2:11-18. Pubmedid: 12466640.
  • Patel NS, Chiu-Tsao ST, Fan P, Tsao HS, Liprie SF, Harrison LB. The use of cylindrical coordinates for treatment planning parameters of an elongated 192Ir source. Int J Radiat Oncol Biol Phys. 2001 Nov.51(4):1093-1102. Pubmedid: 11704334.
  • Patel NS, Fan P, Chiu-Tsao ST, Ravi K, Sherman W, Quon H, Pisch J, Tsao HS, Harrison LB. Ytterbium-169: a promising new radionuclide for intravascular brachytherapy. Cardiovasc Radiat Med. 2001 Jul.2(3):173-180. Pubmedid: 11786324.
  • Patel NS, Chiu-Tsao ST, Tsao HS, Harrison LB. A new treatment planning formalism for catheter-based beta sources used in intravascular brachytherapy. Cardiovasc Radiat Med. 2001 Jul.2(3):157-164. Pubmedid: 11786322.
  • Fan P, Chiu-Tsao S, Patel N, Shih JA, Ravi K, Sherman W, Tsao H, Pisch J, Harrison LB. Influence of metal-artery ratio on the dose reduction due to stent. Cardiovasc Radiat Med. 2001 Jan.2(1):52. Pubmedid: 11068260.
  • Fan P, Chiu-Tsao S, Patel N, Ravi K, Sherman W, Pisch J, Harrison LB, Tsao HS. Yb-169: a promising new isotope for intravascular brachytherapy. Cardiovasc Radiat Med. 2001 Jan.2(1):52-53. Pubmedid: 11068259.
  • Fan P, Chiu-Tsao S, Patel NS, Shih A, Ravi K, Sherman W, Tsao H, Pisch J, Harrison LB. Effect of stent on radiation dosimetry in an in-stent restenosis model. Cardiovasc Radiat Med. 2001 Jan.2(1):18-25. Pubmedid: 11068251.
  • Wolden SL, Zelefsky MJ, Kraus DH, Rosenzweig KE, Chong LM, Shaha AR, Zhang H, Harrison LB, Shah JP, Pfister DG. Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinoma. J Clin Oncol. 2001 Feb.19(4):1105-1110. Pubmedid: 11181675.
  • Patel NS, Chiu-Tsao ST, Williamson JF, Fan P, Duckworth T, Shasha D, Harrison LB. Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachytherapy seed. Med Phys. 2001 Aug.28(8):1761-1769. Pubmedid: 11548947.
  • Patel NS, Chiu-Tsao ST, Fan P, Ahunbay E, Ravi K, Sherman W, Quon H, Pisch J, Tsao HS, Harrison LB. Treatment planning dosimetric parameters for a (90)Y coil source used in intravascular brachytherapy. Cardiovasc Radiat Med. 2001 Apr.2(2):83-92. Pubmedid: 11340012.
  • Harrison LB, Shasha D, White C, Ramdeen B. Radiotherapy-Associated Anemia: The Scope of the Problem. Oncologist. 2000 Jun.5 Suppl 2:1-7. Pubmedid: 10889268.
  • Shasha D, Harrison LB. The role of brachytherapy for palliation. Semin Radiat Oncol. 2000 Jul.10(3):222-239. Pubmedid: 11034633.
  • Alektiar KM, Hu K, Anderson L, Brennan MF, Harrison LB. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys. 2000 Apr.47(1):157-163. Pubmedid: 10758318.
  • Hu KS, Harrison LB. Results and complications of surgery combined with intra-operative radiation therapy for the treatment of locally advanced or recurrent cancers in the pelvis. Semin Surg Oncol. 2000 Apr.18(3):269-278. Pubmedid: 10757894.
  • Harrison LB, Shasha D, White C, Ramdeen B. Radiotherapy-associated anemia: the scope of the problem. Oncologist. 2000.5 Suppl 2:1-7. Pubmedid: 10896322.
  • Salo JC, Paty PB, Guillem J, Minsky BD, Harrison LB, Cohen AM. Surgical salvage of recurrent rectal carcinoma after curative resection: a 10-year experience. Ann Surg Oncol. 1999 Mar.6(2):171-177. Pubmedid: 10082043.
  • Shasha D, Harrison LB, Enker W. Brachytherapy in the treatment of colorectal malignancies. Hematol Oncol Clin North Am. 1999 Jun.13(3):559-575. Pubmedid: 10432429.
  • Hu KS, Harrison LB. Altered fractionation in the treatment of head and neck cancer. Curr Oncol Rep. 1999.1(2):110-123. Pubmedid: 11122807.
  • Harrison LB, Raben A, Pfister DG, Zelefsky M, Strong E, Shah JP, Spiro RH, Shaha A, Kraus DH, Schantz SP, Carper E, Bodansky B, White C, Bosl G. A prospective phase II trial of concomitant chemotherapy and radiotherapy with delayed accelerated fractionation in unresectable tumors of the head and neck. Head Neck. 1998 Sep.20(6):497-503. Pubmedid: 9702535.
  • Harrison LB, Minsky BD, Enker WE, Mychalczak B, Guillem J, Paty PB, Anderson L, White C, Cohen AM. High dose rate intraoperative radiation therapy (HDR-IORT) as part of the management strategy for locally advanced primary and recurrent rectal cancer. Int J Radiat Oncol Biol Phys. 1998 Sep.42(2):325-330. Pubmedid: 9788411.
  • Shasha D, Harrison LB. Elective irradiation of the N0 neck in squamous cell carcinoma of the upper aerodigestive tract. Otolaryng Clin N Am. 1998 Oct.31(5):803-813. Pubmedid: 9735108.
  • Shasha D, Harrison LB, Chiu-Tsao ST. The role of brachytherapy in head and neck cancer. Semin Radiat Oncol. 1998 Oct.8(4):270-281. Pubmedid: 9873105.
  • Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1998 May.124(5):582-587. Pubmedid: 9604987.
  • Merchant TE, Zelefsky MJ, Sheldon JM, LaQuaglia MB, Harrison LB. High-dose rate intraoperative radiation therapy for pediatric solid tumors. Med Pediatr Oncol. 1998 Jan.30(1):34-39. Pubmedid: 9371387.
  • Harrison LB, Lee HJ, Pfister DG, Kraus DH, White C, Raben A, Zelefsky MJ, Strong EW, Shah JP. Long term results of primary radiotherapy with/without neck dissection for squamous cell cancer of the base of tongue. Head Neck. 1998 Dec.20(8):668-673. Pubmedid: 9790286.
  • Bilsky MH, Kraus DH, Strong EW, Harrison LB, Gutin PH, Shah JP. Extended anterior craniofacial resection for intracranial extension of malignant tumors. Am J Surg. 1997 Nov.174(5):565-568. Pubmedid: 9374239.
  • Harrison LB, Zelefsky MJ, Pfister DG, Carper E, Raben A, Kraus DH, Strong EW, Rao A, Thaler H, Polyak T, Portenoy R. Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck. 1997 May.19(3):169-175. Pubmedid: 9142514.
  • Harrison LB. Applications of brachytherapy in head and neck cancer. Semin Surg Oncol. 1997 May.13(3):177-184. Pubmedid: 9143055.
  • Orlikoff RF, Kraus DH, Harrison LB, Ho ML, Gartner CJ. Vocal fundamental frequency measures as a reflection of tumor response to chemotherapy in patients with advanced laryngeal cancer. J Voice. 1997 Mar.11(1):33-39. Pubmedid: 9075174.
  • Kraus DH, Zelefsky MJ, Brock HA, Huo J, Harrison LB, Shah JP. Combined surgery and radiation therapy for squamous cell carcinoma of the hypopharynx. Otolaryngol Head Neck Surg. 1997 Jun.116(6 Pt 1):637-641. Pubmedid: 9215375.
  • Kraus DH, Zelefsky MJ, Brock HAJ, Huo J, Harrison LB, Shah JP. Combined Surgery and Radiation Therapy for Squamous Cell Carcinoma of the Hypopharynx. Otolaryngol Head Neck Surg. 1997 Jun.116(6):637-641. Pubmedid: 29389278.
  • Lee HJ, Zelefsky MJ, Kraus DH, Pfister DG, Strong EW, Raben A, Shah JP, Harrison LB. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phys. 1997 Jul.38(5):995-1000. Pubmedid: 9276364.
  • Devlin PM, Harrison LB. Brachytherapy for soft tissue sarcomas. Cancer Treat Res. 1997 Jan.91:107-128. Pubmedid: 9286492.
  • Alekhteyar KM, Leung DH, Brennan MF, Harrison LB. The effect of combined external beam radiotherapy and brachytherapy on local control and wound complications in patients with high-grade soft tissue sarcomas of the extremity with positive microscopic margin. Int J Radiat Oncol Biol Phys. 1996 Sep.36(2):321-324. Pubmedid: 8892454.
  • Raben A, Mychalczak B, Brennan MF, Minsky B, Anderson L, Casper ES, Harrison LB. Feasibility study of the treatment of primary unresectable carcinoma of the pancreas with 103Pd brachytherapy. Int J Radiat Oncol Biol Phys. 1996 May.35(2):351-356. Pubmedid: 8635943.
  • Pisters PW, Harrison LB, Leung DH, Woodruff JM, Casper ES, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol. 1996 Mar.14(3):859-868. Pubmedid: 8622034.
  • Zelefsky MJ, Gaynor J, Kraus D, Strong EW, Shah JP, Harrison LB. Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma. Am J Surg. 1996 Feb.171(2):258-261. Pubmedid: 8619464.
  • Armstrong JG, Zelefsky MJ, Leibel SA, Burman C, Han C, Harrison LB, Kutcher GJ, Fuks ZY. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol. 1995 Sep.6(7):693-697. Pubmedid: 8664191.
  • Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, Armstrong JG, Zelefsky MJ, Fass DE, Weiss MH. Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation. J Clin Oncol. 1995 Mar.13(3):671-680. Pubmedid: 7884428.
  • Anderson LL, Zlotolow IM, McCormick B, Harrison LB. Controlled mold geometry for surgical deficit treatment planning. Med Phys. 1995 Mar.22(3):307-311. Pubmedid: 7596320.
  • Nag S, Owen JB, Farnan N, Pajak TF, Martinez A, Porter A, Blasko J, Harrison LB. Survey of brachytherapy practice in the United States: a report of the Clinical Research Committee of the American Endocurietherapy Society. Int J Radiat Oncol Biol Phys. 1995 Jan.31(1):103-107. Pubmedid: 7995739.
  • Kraus DH, Pfister DG, Harrison LB, Spiro RH, Strong EW, Zelefsky M, Bosl GJ, Shah JP. Salvage laryngectomy for unsuccessful larynx preservation therapy. Ann Otol Rhinol Laryngol. 1995 Dec.104(12):936-941. Pubmedid: 7492064.
  • Harrison LB, Zelefsky MJ, Armstrong JG, Carper E, Gaynor JJ, Sessions RB. Performance status after treatment for squamous cell cancer of the base of tongue--a comparison of primary radiation therapy versus primary surgery. Int J Radiat Oncol Biol Phys. 1994 Nov.30(4):953-957. Pubmedid: 7960998.
  • Casper ES, Gaynor JJ, Harrison LB, Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer. 1994 Mar.73(6):1644-1651. Pubmedid: 8156491.
  • Pisters PW, Harrison LB, Woodruff JM, Gaynor JJ, Brennan MF. A prospective randomized trial of adjuvant brachytherapy in the management of low-grade soft tissue sarcomas of the extremity and superficial trunk. J Clin Oncol. 1994 Jun.12(6):1150-1155. Pubmedid: 8201376.
  • Ginsberg RJ, Martini N, Zaman M, Armstrong JG, Bains MS, Burt ME, McCormack PM, Rusch VW, Harrison LB. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg. 1994 Jun.57(6):1440-1445. Pubmedid: 8010786.
  • Kraus DH, Pfister DG, Harrison LB, Shah JP, Spiro RH, Armstrong JG, Fass DE, Zelefsky M, Schantz SP, Weiss MH. Larynx preservation with combined chemotherapy and radiation therapy in advanced hypopharynx cancer. Otolaryngol Head Neck Surg. 1994 Jul.111(1):31-37. Pubmedid: 8028939.
  • Harrison LB, Pfister DG, Kraus D, Armstrong JG, Zelefsky MJ, Wiseberg J, Bosl GJ, Strong EW, Shah JP. Management of unresectable malignant tumors at the skull base using concomitant chemotherapy and radiotherapy with accelerated fractionation. Skull Base Surg. 1994 Jul.4(3):127-131. Pubmedid: 17171161. Pmcid: PMC1661798.
  • Kraus DH, Dubner S, Harrison LB, Strong EW, Hajdu SI, Kher U, Begg C, Brennan MF. Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer. 1994 Jul.74(2):697-702. Pubmedid: 8033050.
  • Weiss MH, Harrison LB, Isaacs RS. Use of decision analysis in planning a management strategy for the stage N0 neck. Arch Otolaryngol Head Neck Surg. 1994 Jul.120(7):699-702. Pubmedid: 8018319.
  • Armstrong JG, Anderson LL, Harrison LB. Treatment of liver metastases from colorectal cancer with radioactive implants. Cancer. 1994 Apr.73(7):1800-1804. Pubmedid: 8137203.
  • Harrison LB, Franzese F, Gaynor JJ, Brennan MF. Long-term results of a prospective randomized trial of adjuvant brachytherapy in the management of completely resected soft tissue sarcomas of the extremity and superficial trunk. Int J Radiat Oncol Biol Phys. 1993 Sep.27(2):259-265. Pubmedid: 8407399.
  • Anderson LL, Moni JV, Harrison LB. A nomograph for permanent implants of palladium-103 seeds. Int J Radiat Oncol Biol Phys. 1993 Sep.27(1):129-135. Pubmedid: 8365933.
  • Harrison LB, Zelefsky MJ, Armstrong JG, Schupak KD, Brennan MF. Brachytherapy and Function Preservation in the Localized Management of Soft Tissue Sarcomas of the Extremity. Semin Radiat Oncol. 1993 Oct.3(4):260-269. Pubmedid: 10717078.
  • Harrison LB. Introduction. Semin Radiat Oncol. 1993 Oct.3(4):1. Pubmedid: 10717074.
  • Sessions RB, Lerner DN, Harrison LB. A pivot-shifting palate flap for enhanced exposure of the posterior choanae and nasopharynx. Otolaryngol Head Neck Surg. 1993 Jul.109(1):96-100. Pubmedid: 8393168.
  • Zelefsky MJ, Harrison LB, Fass DE, Armstrong JG, Shah JP, Strong EW. Postoperative radiation therapy for squamous cell carcinomas of the oral cavity and oropharynx: impact of therapy on patients with positive surgical margins. Int J Radiat Oncol Biol Phys. 1993 Jan.25(1):17-21. Pubmedid: 8416876.
  • Kutcher GJ, Leibel SA, Mohan R, Harrison LB, Armstrong JG, Zelefsky MF, LoSasso TJ, Burman CM, Mageras GS, Chui CS. Advances in precision treatment: some aspects of 3D conformal radiation therapy. Front Radiat Ther Oncol. 1993 Jan.27:209-226. Pubmedid: 8504948.
  • Nag S, Abitbol AA, Anderson LL, Blasko JC, Flores A, Harrison LB, Hilaris BS, Martinez AA, Mehta MP, Nori D. Consensus guidelines for high dose rate remote brachytherapy in cervical, endometrial, and endobronchial tumors. Clinical Research Committee, American Endocurietherapy Society. Int J Radiat Oncol Biol Phys. 1993 Dec.27(5):1241-1244. Pubmedid: 8262853.
  • Leibel SA, Kutcher GJ, Mohan R, Harrison LB, Armstrong JG, Zelefsky MJ, LoSasso TJ, Burman CM, Mageras GS, Chui CS, Brewster LJ, Masterson ME, Lo YC, Ling CC, Fuks Z. Three-Dimensional Conformal Radiation Therapy at the Memorial Sloan-Kettering Cancer Center. Semin Radiat Oncol. 1992 Oct.2(4):274-289. Pubmedid: 10717044.
  • Zelefsky MJ, Harrison LB, Armstrong JG. Long-term treatment results of postoperative radiation therapy for advanced stage oropharyngeal carcinoma. Cancer. 1992 Nov.70(10):2388-2395. Pubmedid: 1423170.
  • Harrison LB, Zelefsky MJ, Sessions RB, Fass DE, Armstrong JG, Pfister DG, Strong EW. Base-of-tongue cancer treated with external beam irradiation plus brachytherapy: oncologic and functional outcome. Radiology. 1992 Jul.184(1):267-270. Pubmedid: 1609090.
  • Stock RG, Mychalczak B, Armstrong JG, Curtin JP, Harrison LB. The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys. 1992 Jan.24(4):747-753. Pubmedid: 1429100.
  • Armstrong JG, Martini N, Kris MG, Harrison LB. Induction chemotherapy for non-small cell lung cancer with clinically evident mediastinal node metastases: the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 1992 Jan.23(3):605-613. Pubmedid: 1319427.
  • Armstrong JG, Harrison LB, Thaler HT, Friedlander-Klar H, Fass DE, Zelefsky MJ, Shah JP, Strong EW, Spiro RH. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992 Feb.69(3):615-619. Pubmedid: 1730113.
  • Harrison LB, Sessions RB, Fass DE, Armstrong JG, Hunt M, Spiro RH. Nasopharyngeal brachytherapy with access via a transpalatal flap. Am J Surg. 1992 Aug.164(2):173-175. Pubmedid: 1636898.
  • Brennan MF, Casper ES, Harrison LB, Shiu MH, Gaynor J, Hajdu SI. The role of multimodality therapy in soft-tissue sarcoma. Ann Surg. 1991 Sep.214(3):328-336. Pubmedid: 1929613. Pmcid: PMC1358657.
  • Minsky BD, Cohen AM, Enker WE, Sigurdson E, Harrison LB. Radiation therapy for unresectable rectal cancer. Int J Radiat Oncol Biol Phys. 1991 Oct.21(5):1283-1289. Pubmedid: 1938525.
  • Armstrong JG, Rosenstein MM, Kris MG, Shank BM, Scher HI, Fass DE, Harrison LB, Leibel SA, Fuks ZY. Twice daily thoracic irradiation for limited small cell lung cancer. Int J Radiat Oncol Biol Phys. 1991 Oct.21(5):1269-1274. Pubmedid: 1657842.
  • Shiu MH, Hilaris BS, Harrison LB, Brennan MF. Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb. Int J Radiat Oncol Biol Phys. 1991 Nov.21(6):1485-1492. Pubmedid: 1938557.
  • Piro JD, Battle LW, Harrison LB, D'Elia MJ. Conversion of complete dentures to a radiation shield prosthesis. J Prosthet Dent. 1991 Jun.65(6):731-732. Pubmedid: 2072312.
  • Beitler JJ, Fass DE, Brenner HA, Huvos A, Harrison LB, Leibel SA, Fuks Z. Esthesioneuroblastoma: is there a role for elective neck treatment?. Head Neck. 1991 Jul.13(4):321-326. Pubmedid: 1869434.
  • Zelefsky MJ, Harrison LB, Shiu MH, Armstrong JG, Hajdu SI, Brennan MF. Combined surgical resection and iridium 192 implantation for locally advanced and recurrent desmoid tumors. Cancer. 1991 Jan.67(2):380-384. Pubmedid: 1985733.
  • Goffinet DR, Harrison LB. 192 iridium implantation of base of tongue carcinoma. Int J Radiat Oncol Biol Phys. 1991 Aug.21(3):867. Pubmedid: 1869479.
  • Harrison LB, Pfister DG, Fass DE, Armstrong JG, Sessions RB, Shah JP, Spiro RH, Strong EW, Weisen S, Bosl GJ. Concomitant chemotherapy-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer. Int J Radiat Oncol Biol Phys. 1991 Aug.21(3):703-708. Pubmedid: 1869464.
  • Leibel SA, Kutcher GJ, Harrison LB, Fass DE, Burman CM, Hunt MA, Mohan R, Brewster LJ, Ling CC, Fuks ZY. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991 Apr.20(4):823-833. Pubmedid: 2004961.
  • Armstrong JG, Fass DE, Bains M, Mychalczak B, Nori D, Arbit E, Martini N, Harrison LB. Paraspinal tumors: techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys. 1991 Apr.20(4):787-790. Pubmedid: 1848542.
  • Harrison LB, Armstrong JG, Spiro RH, Fass DE, Strong EW. Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol. 1990 Sep.45(1):52-55. Pubmedid: 2166187.
  • Sessions RB, Harrison LB, Strong EW, Spiro RH. A management plan for tongue base cancer that includes brachytherapy. Otolaryngol Head Neck Surg. 1990 Oct.103(4):599-604. Pubmedid: 2123318.
  • Spiro RH, Kelly J, Vega AL, Harrison LB, Strong EW. Squamous carcinoma of the posterior pharyngeal wall. Am J Surg. 1990 Oct.160(4):420-423. Pubmedid: 2221247.
  • Zelefsky MJ, Harrison LB, Fass DE, Armstrong J, Spiro RH, Shah JP, Strong EW. Postoperative radiotherapy for oral cavity cancers: impact of anatomic subsite on treatment outcome. Head Neck. 1990 Nov.12(6):470-475. Pubmedid: 2258285.
  • Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg. 1990 Mar.116(3):290-293. Pubmedid: 2306346.
  • Harrison LB, Solomon B, Miller S, Fass DE, Armstrong J, Sessions RB. Prospective computer-assisted voice analysis for patients with early stage glottic cancer: a preliminary report of the functional result of laryngeal irradiation. Int J Radiat Oncol Biol Phys. 1990 Jul.19(1):123-127. Pubmedid: 2380077.
  • Armstrong JG, Harrison LB, Spiro RH, Fass DE, Strong EW, Fuks ZY. Observations on the natural history and treatment of recurrent major salivary gland cancer. J Surg Oncol. 1990 Jul.44(3):138-141. Pubmedid: 2370797.
  • Armstrong JG, Harrison LB, Dattoli M, Concepcion R, Minsky BD, Fortner J. The use of a prosthetic tissue expander to displace bowel from a brachytherapy implant site. Int J Radiat Oncol Biol Phys. 1990 Dec.19(6):1521-1523. Pubmedid: 2262376.
  • Schiff PB, Harrison LB, Strong EW, Fass DE, Shah JP, Spiro R, Sessions R, Gerold F, Vikram B, Fuks ZY. Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol. 1990 Apr.43(4):203-208. Pubmedid: 2325418.
  • Harrison LB, Sessions RB, Strong EW, Fass DE, Nori D, Fuks Z. Brachytherapy as part of the definitive management of squamous cancer of the base of tongue. Int J Radiat Oncol Biol Phys. 1989 Dec.17(6):1309-1312. Pubmedid: 2599912.
  • Harrison LB, Fogel TD, Picone JR, Fischer DB, Weissberg JB. Radiation therapy for squamous cell carcinoma of the esophagus. J Surg Oncol. 1988 Jan.37(1):40-43. Pubmedid: 3336219.
  • Harrison LB, Weissberg JB. A technique for interstitial nasopharyngeal brachytherapy. Int J Radiat Oncol Biol Phys. 1987 Mar.13(3):451-453. Pubmedid: 3558031.
  • Harrison LB, Schnall S, Cardinale FS, Farber LR. Multiple myeloma presenting as a pituitary tumor. Int J Radiat Oncol Biol Phys. 1987 Apr.13(4):653-654. Pubmedid: 3558056.
  • Harrison LB, Gutierrez E, Fischer JJ. Retroperitoneal sarcomas: the Yale experience and a review of the literature. J Surg Oncol. 1986 Jul.32(3):159-164. Pubmedid: 3736052.
  • Harrison LB, Worth MH, Carlucci MA. The development of the principles of medical malpractice in the United States. Perspect Biol Med. 1985 Oct.29(1):41-72. Pubmedid: 4069969.
  • Fogel TD, Harrison LB, Son YH. Subsequent upper aerodigestive malignancies following treatment of esophageal cancer. Cancer. 1985 May.55(9):1882-1885. Pubmedid: 3978572.

Patient Comments
Overall Satisfaction
0
★★★★★
★★★★★

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments